Balance Sheet
Accounts PayablesAccumulated DepreciationAssetsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTP) Other Non-Current Assets (2022 - 2025)

60 Degrees Pharmaceuticals (SXTP) has disclosed Other Non-Current Assets for 4 consecutive years, with $143704.0 as the latest value for Q2 2025.

  • On a quarterly basis, Other Non-Current Assets fell 64.47% to $143704.0 in Q2 2025 year-over-year; TTM through Jun 2025 was $143704.0, a 64.47% decrease, with the full-year FY2024 number at $223260.0, down 53.82% from a year prior.
  • Other Non-Current Assets was $143704.0 for Q2 2025 at 60 Degrees Pharmaceuticals, down from $171844.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.7 million in Q2 2023 to a low of $110294.0 in Q3 2024.
  • A 4-year average of $384059.0 and a median of $210894.5 in 2024 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 173.27% in 2023, then tumbled 75.87% in 2024.
  • 60 Degrees Pharmaceuticals' Other Non-Current Assets stood at $176902.0 in 2022, then surged by 173.27% to $483422.0 in 2023, then crashed by 53.82% to $223260.0 in 2024, then plummeted by 35.63% to $143704.0 in 2025.
  • Per Business Quant, the three most recent readings for SXTP's Other Non-Current Assets are $143704.0 (Q2 2025), $171844.0 (Q1 2025), and $223260.0 (Q4 2024).